Stay updated on PD-1 Inhibition in Advanced MPNs Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibition in Advanced MPNs Clinical Trial page.

Latest updates to the PD-1 Inhibition in Advanced MPNs Clinical Trial page
- Check3 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; a minor UI element ('Back to Top') was removed. No changes to pricing, stock, times, or names.SummaryDifference0.4%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.6%
- Check17 days agoChange DetectedThe web page has added specific details about a facility and its location, including the Bronx, New York, and information related to acquired polycythemia vera and pembrolizumab, while removing several related medical topics and terms.SummaryDifference5%
- Check25 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.3%
- Check32 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.SummaryDifference0.7%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.9%
Stay in the know with updates to PD-1 Inhibition in Advanced MPNs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibition in Advanced MPNs Clinical Trial page.